Call: 08045479200
Send Inquiry
Gefitero Tablets
2900 INR
Product Details:
- Indication Non-Small Cell Lung Cancer (NSCLC)
- Dosage Form Tablet
- Salt Composition Gefitinib 250 mg
- Enzyme Types Tyrosine Kinase Inhibitor
- Feature Oral EGFR inhibitor therapy
- Ingredients Gefitinib, Excipients
- Application Cancer Treatment
- Click to View more
X
Gefitero Tablets Price And Quantity
- 2900 INR
Gefitero Tablets Product Specifications
- Tablet
- Tyrosine Kinase Inhibitor
- Non-Small Cell Lung Cancer (NSCLC)
- Oral EGFR inhibitor therapy
- Inhibits EGFR tyrosine kinase
- White to off-white, round film-coated tablets
- Cancer Treatment
- Store in a cool, dry place below 30C, protect from light
- Gefitinib, Excipients
- Gefitinib 250 mg
- Odorless
- 24 months
Gefitero Tablets Trade Information
- 30 , Strips Per Day
- 1 Week
- Yes
- Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
- All India
Product Description
We are creating a brand name in every part of the national market by offering our clients Gefitero Tablets. These tablets are prescribed for the treatment of non-small cell lung cancer in adults. We procure these tablets with the help of our expert agents from the trusted vendors of the market. Tablets contain the salts gefitinib as active ingredients. Offered n tamper proof packaging materials, these tablets are available in different strengths to meet diverse requirements of clients. We offer these Gefitero Tablets at affordable prices to clients.
Features:
- Accurate composition
- Block protein involved in cancer cell growth
- Highly effective in the treatment
Specifications:
| Trade Name | Gefitero (250 mg) |
| Manufacturer | Lyka Labs Limited |
| Unit | 250 mg |
| Type | Tablet |
| Quantity | 10 Tablet |
Effective Oral Therapy for NSCLC
Gefitero Tablets offer a convenient oral option for adults living with Non-Small Cell Lung Cancer. By inhibiting EGFR tyrosine kinase, Gefitinib helps to slow cancer growth and proliferation. Each dose is prescribed by a physician based on individual patient needs and provides targeted therapy with manageable daily administration.
Targeted Action and Patient Suitability
Gefitero is intended for adult patients and acts specifically by blocking the EGFR tyrosine kinase enzyme. This mechanism helps limit the spread of cancerous cells, making it suitable for patients who require precise medical interventions in their cancer care.
Simple Storage and Handling
Keeping Gefitero Tablets in a cool, dry place below 30C and away from direct light helps maintain their efficacy over a shelf life of 24 months. Their odorless and film-coated form ensures ease of handling and ingestion.
FAQs of Gefitero Tablets:
Q: How should I take Gefitero Tablets for optimal therapeutic benefit?
A: Gefitero Tablets should be taken orally as directed by your physician. Swallow the entire tablet with water, without crushing or chewing. Always follow your doctors prescription instructions to maximize treatment efficacy.Q: What conditions is Gefitero indicated for, and who can use it?
A: Gefitero is indicated for the treatment of Non-Small Cell Lung Cancer (NSCLC) in adults. It is not suitable for children, pregnant women, patients with severe liver dysfunction, or those with hypersensitivity to Gefitinib.Q: When is it necessary to avoid taking Gefitero Tablets?
A: You should avoid Gefitero if you are pregnant, have severe liver impairment, or have known hypersensitivity to Gefitinib. Discuss any relevant medical conditions with your physician before starting therapy.Q: Where and how should Gefitero Tablets be stored for safety and potency?
A: Store Gefitero Tablets in a cool, dry place below 30C, away from light and moisture. Do not remove the tablets from their original packaging until required. Proper storage ensures the product maintains its efficacy for up to 24 months.Q: What is the process for obtaining Gefitero Tablets, and is a prescription required?
A: Gefitero Tablets can only be obtained with a valid physicians prescription. As a prescription-only medication, consult your healthcare provider to determine suitability and to initiate targeted lung cancer treatment.Q: How does Gefitero work to treat Non-Small Cell Lung Cancer, and what benefits does it offer?
A: Gefitero contains Gefitinib, which inhibits the activity of EGFR tyrosine kinase in cancer cells. This targeted approach helps to slow the spread of cancer, offering a focused, oral therapy suitable for patients seeking effective management of NSCLC.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Tablets' category
We Mainly Deal in International Market.
Contact Details
PRISSM PHARMA
GST : 27AARFP5752B1Z1
- 12/B, Thacker Industrial Estate, N. M. Joshi Marg, Lower Parel (E),Mumbai - 400011, Maharashtra, India
- Phone :08045479200
Send Inquiry
Developed and Managed by Infocom Network Private Limited.
